Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Deciphering the quality of SARS-CoV-2 specific T-cell response associated with disease severity, immune memory and heterologous response.
Pérez-Gómez A, Gasca-Capote C, Vitallé J, Ostos FJ, Serna-Gallego A, Trujillo-Rodríguez M, Muñoz-Muela E, Giráldez-Pérez T, Praena-Segovia J, Navarro-Amuedo MD, Paniagua-García M, García-Gutiérrez M, Aguilar-Guisado M, Rivas-Jeremías I, Jiménez-León MR, Bachiller S, Fernández-Villar A, Pérez-González A, Gutiérrez-Valencia A, Rafii-El-Idrissi Benhnia M, Weiskopf D, Sette A, López-Cortés LF, Poveda E, Ruiz-Mateos E; Virgen del Rocío Hospital COVID-19 and COHVID-GS Working Teams. Pérez-Gómez A, et al. Among authors: praena segovia j. Clin Transl Med. 2022 Apr;12(4):e802. doi: 10.1002/ctm2.802. Clin Transl Med. 2022. PMID: 35415890 Free PMC article.
Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection.
Pérez-Gómez A, Vitallé J, Gasca-Capote C, Gutierrez-Valencia A, Trujillo-Rodriguez M, Serna-Gallego A, Muñoz-Muela E, Jiménez-Leon MLR, Rafii-El-Idrissi Benhnia M, Rivas-Jeremias I, Sotomayor C, Roca-Oporto C, Espinosa N, Infante-Domínguez C, Crespo-Rivas JC, Fernández-Villar A, Pérez-González A, López-Cortés LF, Poveda E, Ruiz-Mateos E; Virgen del Rocío Hospital COVID-19 Working Team. Pérez-Gómez A, et al. Cell Mol Immunol. 2021 Sep;18(9):2128-2139. doi: 10.1038/s41423-021-00728-2. Epub 2021 Jul 21. Cell Mol Immunol. 2021. PMID: 34290398 Free PMC article.
SARS-CoV-2 viral load in nasopharyngeal swabs is not an independent predictor of unfavorable outcome.
Salto-Alejandre S, Berastegui-Cabrera J, Camacho-Martínez P, Infante-Domínguez C, Carretero-Ledesma M, Crespo-Rivas JC, Márquez E, Lomas JM, Bueno C, Amaya R, Lepe JA, Cisneros JM, Pachón J, Cordero E, Sánchez-Céspedes J; Virgen del Rocío Hospital COVID-19 Working Team. Salto-Alejandre S, et al. Sci Rep. 2021 Jun 21;11(1):12931. doi: 10.1038/s41598-021-92400-y. Sci Rep. 2021. PMID: 34155307 Free PMC article.
A quick prediction tool for unfavourable outcome in COVID-19 inpatients: Development and internal validation.
Salto-Alejandre S, Roca-Oporto C, Martín-Gutiérrez G, Avilés MD, Gómez-González C, Navarro-Amuedo MD, Praena-Segovia J, Molina J, Paniagua-García M, García-Delgado H, Domínguez-Petit A, Pachón J, Cisneros JM. Salto-Alejandre S, et al. Among authors: praena segovia j. J Infect. 2021 Feb;82(2):e11-e15. doi: 10.1016/j.jinf.2020.09.023. Epub 2020 Sep 25. J Infect. 2021. PMID: 32987098 Free PMC article. No abstract available.
Clinical Outcomes of an Innovative Cefazolin Delivery Program for MSSA Infections in OPAT.
Herrera-Hidalgo L, Luque-Márquez R, de Alarcon A, Guisado-Gil AB, Gutierrez-Gutierrez B, Navarro-Amuedo MD, Praena-Segovia J, Carmona-Caballero JM, Fraile-Ramos E, Gutierrez-Valencia A, Lopez-Cortes LE, Gil-Navarro MV. Herrera-Hidalgo L, et al. Among authors: praena segovia j. J Clin Med. 2022 Mar 11;11(6):1551. doi: 10.3390/jcm11061551. J Clin Med. 2022. PMID: 35329878 Free PMC article.
Antifungal treatment administered in OPAT programs is a safe and effective option in selected patients.
Gil-Navarro MV, Luque-Marquez R, Báez-Gutiérrez N, Álvarez-Marín R, Navarro-Amuedo MªD, Praena-Segovia J, Carmona-Caballero JM, Fraile-Ramos E, López-Cortés LE. Gil-Navarro MV, et al. Enferm Infecc Microbiol Clin (Engl Ed). 2020 Dec;38(10):479-484. doi: 10.1016/j.eimc.2020.01.019. Epub 2020 Mar 3. Enferm Infecc Microbiol Clin (Engl Ed). 2020. PMID: 32143891 English, Spanish.
Seven-versus 14-day course of antibiotics for the treatment of bloodstream infections by Enterobacterales: a randomized, controlled trial.
Molina J, Montero-Mateos E, Praena-Segovia J, León-Jiménez E, Natera C, López-Cortés LE, Valiente L, Rosso-Fernández CM, Herrero M, Aller-García AI, Cano Á, Gutiérrez-Gutiérrez B, Márquez-Gómez I, Álvarez-Marín R, Infante C, Roca C, Valiente-Méndez A, Pachón J, Reguera JM, Corzo-Delgado JE, Torre-Cisneros J, Rodríguez-Baño J, Cisneros JM; SHORTEN trial team. Molina J, et al. Among authors: praena segovia j. Clin Microbiol Infect. 2022 Apr;28(4):550-557. doi: 10.1016/j.cmi.2021.09.001. Epub 2021 Sep 9. Clin Microbiol Infect. 2022. PMID: 34508886 Free article. Clinical Trial.
Comparison surprise question against a target index (PALIAR Index) for identifying terminal status in patients with advanced chronic disease.
Hernández Quiles C, Bernabeu Wittel M, Praena Segovia J, Ternero Vega J, Díez Manglano J, Jarava Rol G, Ollero Baturone M. Hernández Quiles C, et al. Rev Clin Esp (Barc). 2017 Mar;217(2):123-124. doi: 10.1016/j.rce.2016.10.014. Epub 2016 Dec 3. Rev Clin Esp (Barc). 2017. PMID: 27919418 English, Spanish. No abstract available.
16 results